Successful use of bioresorbable vascular scaffold in in-stent restenosis previously exposed to vascular brachytherapy

International Journal of Cardiology

Volumn 181, Issue , 2015, Pages 1-2

  Wong, Ka Lam ^a   Fan, Katherine Yu Yan ^a   Jim, Man Hong ^a  

^a GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

Bioresorbable vascular scaffold; In stent re stenosis; Ischemic heart disease

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; STRONTIUM 90; YTTRIUM 90;

AGED; ANTIPLATELET THERAPY; BARE METAL STENT; BARE METAL STENTING; BETA RADIATION; BIORESORBABLE SCAFFOLD; BIORESORBABLE VASCULAR SCAFFOLD; BRACHYTHERAPY; CASE REPORT; CHEMOTHERAPY; DISEASE DURATION; FEMALE; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LETTER; MEDICAL DEVICE COMPLICATION; MEDICAL HISTORY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOTHERAPY EQUIPMENT; RECURRENT DISEASE; RIGHT CORONARY ARTERY; STABLE ANGINA PECTORIS; TREATMENT PLANNING; VASCULAR BRACHYTHERAPY; ADVERSE EFFECTS; BIODEGRADABLE IMPLANT; BLOOD VESSEL PROSTHESIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE COURSE; PATHOPHYSIOLOGY; PROCEDURES; TISSUE SCAFFOLD; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; BLOOD VESSEL PROSTHESIS; BRACHYTHERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84947202370     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.11.190     Document Type: Article

References (10)

1. M.B. Leon, P.S. Teirstein, J.W. Moses, P. Tripuraneni, A.J. Lansky, and S. Jani Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting N. Engl. J. Med. 344 2001 250 256
2. O.O. Alli, P.S. Teirstein, L. Satler, M.H. Sketch Jr., J.J. Popma, and L. Mauri Five-year follow-up of the sirolimus-eluting stents vs vascular brachytherapy for bare metal in-stent restenosis (SISR) trial Am. Heart J. 163 2012 438 445
3. L.N. Oliver, P.G. Buttner, H. Hobson, and J. Golledge A meta-analysis of randomised controlled trials assessing drug-eluting stents and vascular brachytherapy in the treatment of coronary artery in-stent restenosis Int. J. Cardiol. 126 2008 216 223
4. R.A. Byrne, F.J. Neumann, J. Mehilli, S. Pinieck, B. Wolff, and K. Tiroch Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
5. F. Otsuka, M. Vorpahl, M. Nakano, J. Foerst, J.B. Newell, and K. Sakakura Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-and paclitaxel-eluting stents in humans Circulation 129 2014 211 223
6. Y. Onuma, and P.W. Serruys Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123 2011 779 797
7. C. Grasso, G.F. Attizzani, M. Patane, Y. Ohno, D. Capodanno, and C. Tamburino First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography Int. J. Cardiol. 168 2013 4490 4491
8. A.C. Camuglia, and S. Lavi Bioresorbable vascular scaffold implantation for treatment of recurrent in-stent restenosis: insights from optical coherence tomography Int. J. Cardiol. 172 2014 238 239
9. F. Alfonso, J. Nuccio, C. Cuevas, A. Cardenas, N. Gonzalo, and P. Jimenez-Quevedo Treatment of coronary in-stent restenosis with bioabsorbable vascular scaffolds J. Am. Coll. Cardiol. 63 2014 2875
10. A. Ielasi, A. Latib, T. Naganuma, B. Cortese, K. Sato, and T. Miyazaki Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis Int. J. Cardiol. 173 2014 513 514